|
|
Value in Health 3rd Special Issue:
SPECIAL ISSUE EDITORS, EDITORIAL BOARD AND SPONSORS EDITORIAL Bridging the Gap in Pharmacoeconomics and Outcomes Research
between Researchers, Policymakers, and Practitioners in the Asia-
Pacific Region ECONOMIC EVALUATION Cost-Effectiveness Analysis for Antidepressants and Cognitive
Behavioral Therapy for Major Depression in Thailand The Effects of Medication Supply on Hospitalizations and Health-Care Costs in Patients with Chronic Heart Failure Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccine in Taiwan: A Transmission Dynamic Modeling
Approach Evidence to Inform Decision Makers in Thailand: A Cost-Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis Cost and Effectiveness Evaluation of Prophylactic HPV Vaccine in Developing Countries Availability, Health-Care Costs, and Utilization Patterns of Biologics in Taiwan Cost of Illness and Quality of Life of Patients with Rheumatoid Arthritis in South Korea Cost-Effectiveness of Various Tuberculosis Control Strategies in Thailand Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese
Setting: A Health Economic Model Based on the PREDICTIVE Study PATIENT-REPORTED OUTCOMES A Multilevel Analysis of Regional and Individual Effects on Methadone Maintenance Treatment in Taiwan The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore Health Utility Measured with EQ-5D in Thai Patients Undergoing Peritoneal Dialysis PREFERENCE-BASED ASSESSMENT Estimating an EQ-5D Value Set for Malaysia Using Time Trade-Off and Visual Analogue Scale Methods HEALTH POLICY ANALYSIS Eliciting Public Preference for Health-Care Resource Allocation in South Korea Impact of the Introduction of Government Use Licenses on the Drug Expenditure on Seven Medicines in Thailand Different Policy Outcomes of the New Drugs and Currently Listed Drugs under the Positive List System in South Korea Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea Successful Implementation of a P&T-Approved Therapeutic Interchange Program of Angiotensin II Receptor Blockers in a Medical Center in Taiwan Antibiotic-Prescribing Practices of Primary Care Prescribers for Acute Diarrhea in New Delhi, India DECISION-MAKER COMMENTARY Drug Reimbursement Decision-Making in Thailand, China, and South Korea National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and
Opportunities Health-Care Data Collecting, Sharing, and Using in Thailand, China Mainland, South Korea, Taiwan, Japan, and
Malaysia Pharmacoeconomics and Outcomes Research in Asia. Value Health 2012; 15(Suppl.1): S139-142 To see this issue online, go to Value in Health. Back to Asia Consortium main page
|
This issue includes 24 articles selected mostly from the presentations at the ISPOR 3rd Asia Pacific Conference held in September 2008 in Seoul, South Korea. All articles underwent the usual anonymous process of peer review, and they are grouped into two categories-“full” and “condensed” papers under four sections: policy review, economic evaluation, cost analysis, QOL/outcomes study. Among the ten full papers are three multi-country papers, covering HTA policies in a total of ten Asian health care systems. For those “condensed”, all supplementary materials are published on ISPOR ViH website. “The articles cover a wide range of HTA related scientific issues such as societal burden of disease, cost effectiveness of various interventions, policy development, ICER (incremental cost effectiveness ratio) threshold, utility measurement tool, HTA attitudes among decision makers and researchers, pharmacoeconomic submission guideline, and outcomes measurement.” (Editorial) |
Contact ISPOR @ info@ispor.org
| View Legal Disclaimer |